Editorial: potassium-competitive acid blockers for acid-related diseases-tegoprazan, a new kid on the block

Aliment Pharmacol Ther. 2019 Oct;50(8):960-962. doi: 10.1111/apt.15480.

Authors

Carmelo Scarpignato^{1

2

3}, Richard H Hunt⁴

Affiliations

¹ Faculty of Medical Sciences, LUdeS Lugano Campus, Lugano, Switzerland.
² United Campus of Malta, Msida, Malta.
³ Faculty of Medicine, Chinese University of Hong Kong, Ma Liu Shui, Hong Kong.
⁴ Division of Gastroenterology and Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, ON, Canada.

PMID: 31591775
DOI: 10.1111/apt.15480

No abstract available

Publication types

Editorial
Comment

MeSH terms

Benzene Derivatives
Humans
Imidazoles*
Male
Potassium*

Substances

Benzene Derivatives
Imidazoles
Potassium
tegoprazan